Healio

FDA approves Xeomin as first neurotoxin for simultaneous treatment of facial lines

Please provide your email address to receive an email when new articles are posted on . Xeomin is the first neurotoxin that can simultaneously treat frown lines, forehead lines and crow’s feet. Xeomin ...
MarketWatch

Merz Aesthetics Celebrates 15 Years of XEOMIN(R) (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign

Merz Aesthetics, the world's largest dedicated medical aesthetics business, celebrates 15 years since its flagship brand XEOMIN(R) was first approved for aesthetic use by the U.S. Food and Drug ...
Monthly Prescribing Reference

Xeomin Approved for Simultaneous Treatment of Upper Facial Lines

When treating all 3 areas simultaneously, the maximum recommended dose is 64 Units. The Food and Drug Administration (FDA) has expanded the approval of Xeomin ® (incobotulinumtoxinA) to include ...
MM&M

Merz Aesthetics celebrates Xeomin’s 15-year anniversary with refreshed brand campaign

Merz is embarking on a multichannel campaign that includes assets like in-office materials for patients and HCPs as digital ads on Instagram. Additionally, Merz is hosting a monthlong sweepstakes from ...
Business Wire

Merz Therapeutics Announces First Patients Enrolled in Two Phase III Trials Investigating XEOMIN ® (incobotulinumtoxinA) for Migraine Prevention

“The enrollment of the first patients in the MINT trials marks an important milestone as we aim to address persistent gaps in migraine care by advancing a new neurotoxin option for patients.” MINT-E ...
Morningstar

Merz Aesthetics Celebrates 15 Years of XEOMIN® (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign

Merz Aesthetics Celebrates 15 Years of XEOMIN® (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign In addition, Merz Aesthetics is also launching a new, ...